Jove
Visualize
Contact Us

Related Experiment Videos

Ischaemic optic neuropathy.

S S Hayreh1

  • 1Ocular Vascular Division, Department of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, USA. sohan-hayreh@uiowa.ed

Indian Journal of Ophthalmology
|February 24, 2001
PubMed
Summary

Anterior ischaemic optic neuropathy (AION) has two forms: arteritic (A-AION) and non-arteritic (NA-AION). Nocturnal hypotension is a key risk factor for NA-AION, with potential iatrogenic causes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploding head syndrome: new observations.

European journal of neurology·2020
Same author

Comment on 'The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary'.

Eye (London, England)·2016
Same author

Orbital vascular anatomy.

Eye (London, England)·2006
Same author

Posterior ischaemic optic neuropathy: clinical features, pathogenesis, and management.

Eye (London, England)·2004
Same author

Count and size of macular drusen correlated with the parafoveal annular reflex.

The British journal of ophthalmology·2004
Same author

Role of thrombocytosis in diagnosis of giant cell arteritis and differentiation of arteritic from non-arteritic anterior ischemic optic neuropathy.

European journal of ophthalmology·2004
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Ophthalmology
  • Neurology
  • Vascular Medicine

Background:

  • Ischaemic optic neuropathy (ION) comprises anterior (AION) and posterior (PION) types, differing significantly in pathogenesis.
  • AION affects the optic nerve head (ONH), often linked to posterior ciliary artery (PCA) ischemia.
  • AION presents as arteritic (A-AION) or non-arteritic (NA-AION), with NA-AION being more common and visually debilitating in older adults.

Purpose of the Study:

  • To elucidate the underlying causes, clinical features, pathogenesis, and management of AION.
  • To investigate the role of nocturnal arterial hypotension as a risk factor in NA-AION.
  • To differentiate between A-AION and NA-AION and discuss their respective treatments.

Main Methods:

  • Review and discussion of basic scientific principles related to AION.
  • Analysis of risk factors contributing to NA-AION development and progression.
  • Examination of clinical parameters for differentiating AION subtypes.

Main Results:

  • Nocturnal arterial hypotension identified as a significant risk factor for NA-AION.
  • Aggressive antihypertensive medication, especially at bedtime, may contribute to nocturnal hypotension and iatrogenic NA-AION.
  • A-AION is an emergency requiring immediate corticosteroid treatment to prevent vision loss.

Conclusions:

  • Understanding AION pathogenesis is crucial for effective management.
  • Risk factor reduction, particularly addressing nocturnal hypotension, is key for NA-AION.
  • Prompt recognition and treatment of A-AION with corticosteroids are vital.

Related Experiment Videos